Arrowhead Pharmaceuticals (ARWR) has an average rating of buy and mean price target of $91.82, according to analysts polled by FactSet.
What else is happening in Research?
Research
BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target
West Pharmaceutical Services (WST) has an average rating of buy and mean price target of $383.93, according to analysts polled by FactSet.Price: $356.76, Change: $+3.05, Percent Change: +0.86%
$WST
Research
BofA Securities Upgrades Saia to Buy From Neutral, Raises Price Target to $502 From $499
Saia (SAIA) has an average rating of overweight and mean price target of $469.60, according to analysts polled by FactSet.Price: $430.76, Change: $+9.94, Percent Change: +2.36%
$SAIA
Research
AlphaValue/Baader Europe Upgrades Barry Callebaut Group to Add, Trims PT
AlphaValue/Baader Europe on Monday upgraded Swiss chocolate and cocoa products company Barry Callebaut (BARN.SW) to add from reduce, while lowering its price target to 1,277 francs from 1,281 francs.
$BARN.SW